Glaxosmithkline | Despesas Operacionais





Despesas Operacionais Alterar Data
AbbVie USD 10.81B 13.45B 2025-12
Amgen USD 5.9B 773M 2025-12
AstraZeneca USD 12.53B 4.16B 2025-12
Aurora Cannabis CAD 146.03M 27.79M 2025-09
Bausch Health Companies USD 1.96B 109M 2025-09
Bristol-Myers Squibb USD 8.3B 10.25B 2025-12
Canopy Growth CAD 80.99M 8.64M 2025-09
Corcept Therapeutics USD 197.42M 29.66M 2025-09
Drreddys Laboratories INR 72.94B 4.33B 2025-12
Eli Lilly USD 10.31B 1.09B 2025-12
GlaxoSmithKline GBP 7.18B 1.42B 2025-12
Glaxosmithkline GBP 7.77B 2.22B 2025-09
J&J USD 18.97B 2.38B 2025-12
Merck USD 10.16B 558M 2025-12
Novartis USD 9.86B 115M 2025-09
Pacira USD 166.36M 4.5M 2025-09
Perrigo USD 949.9M 50.8M 2025-09
Pfizer USD 12.91B 79.89B 2025-12
Phibro Animal Health USD 332.36M 20.68M 2025-12
Prestige Brands USD 200.95M 6.51M 2025-12
Roche Holding CHF 21.01B 10.84B 2025-12
Sanofi EUR 10.51B 1.21B 2025-12
Supernus Pharmaceuticals USD 252.29M 98.98M 2025-09
Takeda JPY 1.02T 400.98B 2025-12
Teva Pharmaceutical Industries USD 4.22B 812M 2025-12
Zoetis USD 1.55B 3.85B 2025-12


Glaxosmithkline Despesas Operacionais - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.